Plus Therapeutics, Inc. (PSTV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Plus Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.78x | -0.59x | -0.00x | -0.00x | -0.00x | -0.00x |
| P/B Ratio | 9.98x | -0.85x | -0.00x | 0.00x | 0.00x | 0.00x |
| P/S Ratio | 7.65x | 1.31x | 0.00x | 0.04x | 0.00x | 0.03x |
| Profitability | ||||||
| Gross Margin | 91.5% | 85.4% | -97.2% | -217.9% | 0.0% | -791.1% |
| Operating Margin | -293.5% | -252.3% | -271.1% | -8800.0% | 0.0% | -3163.0% |
| Net Margin | -429.4% | -222.8% | -271.0% | -9051.3% | 0.0% | -2719.8% |
| EBITDA Margin | -284.9% | -144.3% | -258.4% | -8416.1% | 0.0% | -2784.5% |
| Liquidity | ||||||
| Current Ratio | 1.23x | 0.34x | 0.92x | 1.84x | 3.36x | 1.07x |
| Quick Ratio | 1.23x | 0.34x | 0.92x | 1.84x | 3.36x | 1.07x |
| Leverage | ||||||
| Debt/Equity | 0.21x | -0.38x | -3.10x | 0.89x | 0.65x | 2.31x |
YoY = year-over-year change. Source: FMP..